Cyclerion Therapeutics Inc (CYCN) — Cash Flow Reinvestment Rate
Latest as of December 2024:
0.00x
Cyclerion Therapeutics Inc (CYCN) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $360.00K. See CYCN net asset quality score to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$360.00K
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Cyclerion Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Cyclerion Therapeutics Inc. For live market cap and broader valuation context, see Cyclerion Therapeutics Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow